Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC
Clinical trial NCT05494697 · SUSPENDED
Trial details
- NCT number
- NCT05494697
- Sponsor
- AIM ImmunoTech Inc.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-12-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.